Starling Oncology, Inc. STLN
4.06 USD +0.05 (+1.37%)
Nov 10, 2026, 9:31 AM EST
3.97 Day range 4.20
2.32 52-week range 7.13
- YTD
- +13.90%
- 1 year
- +22.51%
- Market cap
- 413.57M
- EPS (ttm)
- -0.28
- YTD return
- +13.90%
- 1-year return
- +22.51%
- Volume
- 46.98K
- Avg volume
- 1.75M
- Open
- 3.97
- Previous close
- 4.00
- Day's range
- 3.97 – 4.20
- 52-week range
- 2.32 – 7.13
5D -2.27 (-36.20%)
Financials — quick view
STLN Revenue — quarterly 169.77M
STLN Net income — quarterly -13.29M
STLN EPS — quarterly -0.13
News
B. Riley Securities Reiterates Buy on Starling Oncology, Lowers Price Target to $10 
Oncology Institute Q3 Earnings Call Highlights 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
BTIG Maintains Buy on Starling Oncology, Raises Price Target to $10 
Starling Oncology Q3 2026 Earnings Call Transcript - Starling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est
Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate - Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
12 Health Care Stocks Moving In Friday's After-Market Session - Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.